KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Retained Earnings (2016 - 2025)

Exact Sciences (EXAS) has disclosed Retained Earnings for 16 consecutive years, with -$4.7 billion as the latest value for Q4 2025.

  • On a quarterly basis, Retained Earnings fell 4.62% to -$4.7 billion in Q4 2025 year-over-year; TTM through Dec 2025 was -$4.7 billion, a 4.62% decrease, with the full-year FY2025 number at -$4.7 billion, down 4.62% from a year prior.
  • Retained Earnings was -$4.7 billion for Q4 2025 at Exact Sciences, down from $3.2 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $4.6 million in Q3 2024 to a low of -$4.7 billion in Q4 2025.
  • A 5-year average of -$2.0 billion and a median of -$2.3 billion in 2021 define the central range for Retained Earnings.
  • Peak YoY movement for Retained Earnings: surged 121.2% in 2021, then plummeted 497162.93% in 2024.
  • Exact Sciences' Retained Earnings stood at -$1.4 million in 2021, then tumbled by 262.86% to -$5.2 million in 2022, then tumbled by 66156.21% to -$3.5 billion in 2023, then decreased by 29.66% to -$4.5 billion in 2024, then dropped by 4.62% to -$4.7 billion in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Retained Earnings are -$4.7 billion (Q4 2025), $3.2 million (Q3 2025), and $3.1 million (Q2 2025).